{"transactions":[{"id":737930,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Units in ProKidney Holdings, LLC","published_at":"2026-06-15T21:32:30.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":false,"shares":163857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":163857},"source":{"system":"sec-edgar","filing":"0001193125-26-271337","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526271337/ownership.xml","form_type":"4"}},{"id":737929,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class B Common Stock","published_at":"2026-06-15T21:32:30.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":false,"shares":163857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Class B Common Stock and the Common Units in ProKidney Holdings LLC (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Amended and Restated Exchange Agreement, dated as of July 1, 2025, and and the Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings, LLC, each Class B Common Stock, together with a paired Common Unit, may be exchanged for Class A Common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Common Stock do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Common Stock do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":163857},"source":{"system":"sec-edgar","filing":"0001193125-26-271337","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526271337/ownership.xml","form_type":"4"}},{"id":737928,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-15T21:32:30.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":true,"shares":163857,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":327713,"source":{"system":"sec-edgar","filing":"0001193125-26-271337","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526271337/ownership.xml","form_type":"4"}},{"id":868044,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2026-03-03T12:58:18.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2026."}],"balance_after":600000,"derivative":{"exercise_price":2.24,"expiration_date":"2036-03-01","underlying":"Class A Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001193125-26-086725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526086725/ownership.xml","form_type":"4"}},{"id":1229311,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2025-03-04T21:41:36.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2025."}],"balance_after":650000,"derivative":{"exercise_price":1.23,"expiration_date":"2035-03-01","underlying":"Class A Ordinary Shares","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0000950170-25-032249","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025032249/ownership.xml","form_type":"4"}},{"id":1443015,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Units in ProKidney LP","published_at":"2024-08-02T20:03:07.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":false,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":163857,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":81928},"source":{"system":"sec-edgar","filing":"0000950170-24-089935","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024089935/ownership.xml","form_type":"4"}},{"id":1443014,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class B Ordinary Shares","published_at":"2024-08-02T20:03:07.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":false,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Class B Ordinary Shares and the Common Units in ProKidney LP (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."}],"balance_after":163857,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":81928},"source":{"system":"sec-edgar","filing":"0000950170-24-089935","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024089935/ownership.xml","form_type":"4"}},{"id":1443013,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Ordinary Shares","published_at":"2024-08-02T20:03:07.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":true,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":163856,"source":{"system":"sec-edgar","filing":"0000950170-24-089935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024089935/ownership.xml","form_type":"4"}},{"id":1597207,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2024-03-05T21:12:23.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":234742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 50% on the 1st anniversary of March 1, 2024 and the remaining 50% vests in substantially equal monthly installments for 12 months thereafter."}],"balance_after":234742,"derivative":{"exercise_price":1.61,"expiration_date":"2034-03-01","underlying":"Class A Ordinary Shares","underlying_shares":234742},"source":{"system":"sec-edgar","filing":"0000950170-24-025916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024025916/ownership.xml","form_type":"4"}},{"id":1597206,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2024-03-05T21:12:23.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2024."}],"balance_after":300000,"derivative":{"exercise_price":1.61,"expiration_date":"2034-03-01","underlying":"Class A Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950170-24-025916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024025916/ownership.xml","form_type":"4"}},{"id":1656952,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Units in ProKidney LP","published_at":"2024-02-06T21:07:30.000Z","date":"2024-02-05","kind":"exercise","planned":false,"acquired":false,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":245785,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":81928},"source":{"system":"sec-edgar","filing":"0000950170-24-011720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024011720/ownership.xml","form_type":"4"}},{"id":1656951,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class B Ordinary Shares","published_at":"2024-02-06T21:07:30.000Z","date":"2024-02-05","kind":"exercise","planned":false,"acquired":false,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Class B Ordinary Shares and the Common Units in ProKidney LP (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."}],"balance_after":245785,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":81928},"source":{"system":"sec-edgar","filing":"0000950170-24-011720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024011720/ownership.xml","form_type":"4"}},{"id":1656950,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Ordinary Shares","published_at":"2024-02-06T21:07:30.000Z","date":"2024-02-05","kind":"exercise","planned":false,"acquired":true,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":81928,"source":{"system":"sec-edgar","filing":"0000950170-24-011720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024011720/ownership.xml","form_type":"4"}},{"id":2052657,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2023-01-18T21:11:21.000Z","date":"2023-01-16","kind":"grant","acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on January 16, 2023."}],"balance_after":290000,"derivative":{"exercise_price":8.43,"expiration_date":"2033-01-16","underlying":"Class A Ordinary Shares","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001209191-23-003713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000120919123003713/doc4.xml","form_type":"4"}},{"id":2077332,"issuer":{"id":7608,"kind":"organization","name":"Longeveron Inc.","symbol":"LGVN"},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-12-22T23:00:12.000Z","date":"2022-12-21","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on first anniversary of date of grant."}],"balance_after":5000,"derivative":{"exercise_price":3,"expiration_date":"2032-12-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001214659-22-015249","document":"marketforms-57533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721484/000121465922015249/marketforms-57533.xml","form_type":"4"}},{"id":2133045,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2022-10-24T21:50:32.000Z","date":"2022-10-20","kind":"grant","acquired":true,"shares":696793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on October 19, 2022."}],"balance_after":696793,"derivative":{"exercise_price":10.33,"expiration_date":"2032-10-20","underlying":"Class A Ordinary Shares","underlying_shares":696793},"source":{"system":"sec-edgar","filing":"0001209191-22-054429","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000120919122054429/doc4.xml","form_type":"4"}},{"id":2208107,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Units in ProKidney LP","published_at":"2022-07-14T01:29:52.000Z","date":"2022-07-11","kind":"grant","acquired":true,"shares":327713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Common Unit may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, be exchanged, together with the paired Class B Ordinary Share, into a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Common Unit may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, be exchanged, together with the paired Class B Ordinary Share, into a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"These 327,713 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2026. The Common Units and the PMEL RCUs do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These 327,713 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2026. The Common Units and the PMEL RCUs do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These 327,713 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2026. The Common Units and the PMEL RCUs do not expire."}],"balance_after":327713,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":327713},"source":{"system":"sec-edgar","filing":"0000950103-22-012370","document":"dp177005_4-girolamo.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095010322012370/dp177005_4-girolamo.xml","form_type":"4"}},{"id":2208106,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class B Ordinary Shares","published_at":"2022-07-14T01:29:52.000Z","date":"2022-07-11","kind":"grant","acquired":true,"shares":327713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Class B Ordinary Share has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the Securities and Exchange Commission on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (\"ProKidney\") (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These 327,713 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney, dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2026, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These 327,713 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney, dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2026, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These 327,713 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney, dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2026, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."}],"balance_after":327713,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":327713},"source":{"system":"sec-edgar","filing":"0000950103-22-012370","document":"dp177005_4-girolamo.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095010322012370/dp177005_4-girolamo.xml","form_type":"4"}},{"id":2371351,"issuer":{"id":7608,"kind":"organization","name":"Longeveron Inc.","symbol":"LGVN"},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-02-25T23:30:16.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units subject to time-based vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 Restricted Stock Units."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001214659-22-003245","document":"marketforms-55453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721484/000121465922003245/marketforms-55453.xml","form_type":"4"}},{"id":2434323,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO, SVP of Corp Dev"}}],"security":"Common Stock","published_at":"2022-01-18T21:04:55.000Z","date":"2022-01-14","kind":"tax_withholding","acquired":false,"shares":2158,"price":0.8204,"value":1770.4232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 119,000 unvested restricted stock."}],"balance_after":160827,"source":{"system":"sec-edgar","filing":"0001891257-22-000004","document":"wf-form4_164253988021529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000189125722000004/wf-form4_164253988021529.xml","form_type":"4"}},{"id":2434322,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO, SVP of Corp Dev"}}],"security":"Common Stock","published_at":"2022-01-18T21:04:55.000Z","date":"2022-01-13","kind":"tax_withholding","acquired":false,"shares":2563,"price":0.8063,"value":2066.5469,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 123,000 unvested restricted stock."}],"balance_after":162985,"source":{"system":"sec-edgar","filing":"0001891257-22-000004","document":"wf-form4_164253988021529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000189125722000004/wf-form4_164253988021529.xml","form_type":"4"}},{"id":2437222,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO, SVP of Corp Dev"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-12T21:20:23.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."}],"balance_after":65000,"derivative":{"exercise_price":0.917,"exercise_date":"2022-01-10","expiration_date":"2032-01-10","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001891257-22-000002","document":"wf-form4_164202240462407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/320017/000189125722000002/wf-form4_164202240462407.xml","form_type":"4"}},{"id":2437221,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO, SVP of Corp Dev"}}],"security":"Common Stock","published_at":"2022-01-12T21:20:23.000Z","date":"2022-01-11","kind":"tax_withholding","acquired":false,"shares":4722,"price":0.8651,"value":4085.0022,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 127,750 unvested restricted stock."}],"balance_after":165548,"source":{"system":"sec-edgar","filing":"0001891257-22-000002","document":"wf-form4_164202240462407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/320017/000189125722000002/wf-form4_164202240462407.xml","form_type":"4"}},{"id":2437220,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO, SVP of Corp Dev"}}],"security":"Common Stock","published_at":"2022-01-12T21:20:23.000Z","date":"2022-01-10","kind":"tax_withholding","acquired":false,"shares":17405,"price":0.917,"value":15960.385,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld as payment of a tax liability on vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 136,500 unvested restricted stock."}],"balance_after":170270,"source":{"system":"sec-edgar","filing":"0001891257-22-000002","document":"wf-form4_164202240462407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/320017/000189125722000002/wf-form4_164202240462407.xml","form_type":"4"}},{"id":2437219,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO, SVP of Corp Dev"}}],"security":"Common Stock","published_at":"2022-01-12T21:20:23.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":129000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 129,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 136,500 unvested restricted stock."}],"balance_after":187675,"source":{"system":"sec-edgar","filing":"0001891257-22-000002","document":"wf-form4_164202240462407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000189125722000002/wf-form4_164202240462407.xml","form_type":"4"}}]}